OBJECTIVE: Total parenteral nutrition (TPN), with the complete removal of enteral nutrition, results in marked changes in intestinal intraepithelial lymphocyte (IEL) function and phenotype. Previous work shows that TPN results in a loss of intestinal epithelial cell-derived interleukin-7 (IL-7), and this loss may play an important role in development of such TPN-associated IEL changes. METHODS: To further understand this relation, we generated a transgenic mouse (IL-7), which overexpresses IL-7 specifically in intestinal epithelial cells. We hypothesized that this localized overexpression would attenuate many of the observed TPN-associated IEL changes. RESULTS: Our study showed that TPN administration led to significant changes in IEL phenotype, including a marked decline in the CD8alphabeta+, CD4+, and alphabeta-TCR+ populations. IEL basal proliferation decreased 1.7-fold compared with wild-type TPN mice. TPN administration in wild-type mice resulted in several changes in IEL-derived cytokine expression. IL-7 mice given TPN, however, maintained IEL proliferation, and sustained normal IEL numbers and phenotype. CONCLUSIONS: We conclude that specific intestinal IL-7 overexpression significantly attenuated many IEL changes in phenotype and function after TPN administration. These findings suggest a mechanism by which TPN results in observed IEL changes.
OBJECTIVE: Total parenteral nutrition (TPN), with the complete removal of enteral nutrition, results in marked changes in intestinal intraepithelial lymphocyte (IEL) function and phenotype. Previous work shows that TPN results in a loss of intestinal epithelial cell-derived interleukin-7 (IL-7), and this loss may play an important role in development of such TPN-associated IEL changes. METHODS: To further understand this relation, we generated a transgenicmouse (IL-7), which overexpresses IL-7 specifically in intestinal epithelial cells. We hypothesized that this localized overexpression would attenuate many of the observed TPN-associated IEL changes. RESULTS: Our study showed that TPN administration led to significant changes in IEL phenotype, including a marked decline in the CD8alphabeta+, CD4+, and alphabeta-TCR+ populations. IEL basal proliferation decreased 1.7-fold compared with wild-type TPN mice. TPN administration in wild-type mice resulted in several changes in IEL-derived cytokine expression. IL-7mice given TPN, however, maintained IEL proliferation, and sustained normal IEL numbers and phenotype. CONCLUSIONS: We conclude that specific intestinal IL-7 overexpression significantly attenuated many IEL changes in phenotype and function after TPN administration. These findings suggest a mechanism by which TPN results in observed IEL changes.
Authors: K Maki; S Sunaga; Y Komagata; Y Kodaira; A Mabuchi; H Karasuyama; K Yokomuro; J I Miyazaki; K Ikuta Journal: Proc Natl Acad Sci U S A Date: 1996-07-09 Impact factor: 11.205
Authors: M Watanabe; Y Ueno; T Yajima; S Okamoto; T Hayashi; M Yamazaki; Y Iwao; H Ishii; S Habu; M Uehira; H Nishimoto; H Ishikawa; J Hata; T Hibi Journal: J Exp Med Date: 1998-02-02 Impact factor: 14.307
Authors: Jennifer J Freeman; Yongjia Feng; Farokh R Demehri; Peter J Dempsey; Daniel H Teitelbaum Journal: FASEB J Date: 2015-03-17 Impact factor: 5.191
Authors: Matthew W Ralls; Farokh R Demehri; Yongjia Feng; Kathleen M Woods Ignatoski; Daniel H Teitelbaum Journal: Surgery Date: 2015-02-20 Impact factor: 3.982
Authors: Eiichi A Miyasaka; Yongjia Feng; Valeriy Poroyko; Nicole R Falkowski; John Erb-Downward; Merritt G Gillilland; Katie L Mason; Gary B Huffnagle; Daniel H Teitelbaum Journal: J Immunol Date: 2013-05-10 Impact factor: 5.422